The Rojas ReportAHA Intelligence

Melinda S. Hancock

Executive Vice President & Chief Financial Officer | AHA Board of Trustees Member | Sentara Health | AHA Board of Trustees Member

10 Red Flags
Affiliations
  • •Executive Vice President & Chief Financial Officer, Sentara Health (Virginia Beach, VA) — Appointed CFO effective January 1, 2025, succeeding Robert Broermann who retired after 30+ years. Sentara is one of the top 20 largest not-for-profit integrated health systems in the U.S., operating across the Mid-Atlantic and Southeast.
  • •AHA Board of Trustees — Elected for a three-year term beginning January 1, 2026. The Board is the highest policymaking body of the AHA and has ultimate authority over governance, management, and finances of the association.
  • •AHA Regional Policy Board 3 — Member from 2021–2023, providing a pipeline to the national board seat.
  • •Chief Transformation Officer & EVP (2022–2024) — Established Sentara's first transformation office and led implementation of the system's new strategic plan.
  • •Chief Administrative Officer (July 2021–2022) — Oversaw internal audit, compliance, legal services, privacy, supply chain, enterprise analytics, and growth functions.
  • •Chief Administrative Officer & Chief Financial Officer, VCU Health System (Richmond, VA) — From 2016; made significant contributions to infrastructure development at Virginia's flagship academic medical center.
  • •Partner, Dixon Hughes Goodman LLP (now Forvis Mazars) — Led the payment model team developing products related to the transformation from volume-based to value-based reimbursement. This consulting role gave Hancock deep insight into payer-provider economics.
  • •Senior Vice President & Chief Financial Officer, Bon Secours Health System (Virginia Market) — Market CFO overseeing Bon Secours' Virginia operations. Also served as Interim CFO at Bon Secours Charity Health System.
Financial / Compensation
  • •System Revenue: Sentara Health is a ~$10 billion integrated health system (combined hospital, physician, and health plan revenue). It ranks among the top 20 largest not-for-profit health systems nationally.
  • •Net Assets: Sentara has amassed approximately $6 billion in net assets — a figure repeatedly cited by critics noting the system pays no federal income tax as a 501(c)(3).
  • •Tax-Exempt Entity: Sentara Health (EIN: 52-1271901) files Form 990 with the IRS. The most recent filing was submitted November 6, 2025, covering the December 2024 tax year. Sentara Hospitals (EIN: 54-1547408) files separately.
  • •Optima Health / Sentara Health Plans: Sentara Health Plans (EIN: 54-1283337), operating as Optima Health, is a nonprofit health plan subsidiary with over 1 million members across commercial, Medicaid, and Medicare lines in Virginia and Florida. Sentara merged Virginia Premier into Optima Health in 2023, consolidating its insurance operations. Optima holds the largest Medicaid market share in Virginia, serving approximately 708,000 Medicaid recipients.
  • •Hancock became CFO on January 1, 2025, so her CFO-level compensation would first appear on Sentara's Form 990 for the December 2025 tax year (likely filed late 2026).
  • •Prior disclosure: As Chief Transformation Officer / EVP (2022–2024), Hancock would appear on Schedule J of Sentara's 990 filings if among the highest-compensated employees. Extracted data from recent filings is not yet available on ProPublica's Nonprofit Explorer; the raw PDFs must be reviewed.
  • •Compensation benchmarks: Sentara's 2018 Form 990 disclosed 21 highest-compensated employees, with the top earner receiving $6.1 million (Michael M. Dudley, former officer, including related-organization compensation). The CFO of a $10 billion not-for-profit health system typically earns $1.5–3.5 million in total compensation (base salary + incentive + deferred compensation + benefits), based on comparable system CFO disclosures. Hancock's total package is likely in this range.
  • •HFMA national chairmanship and AHA board service are unpaid governance roles but confer significant reputational capital and network access that indirectly benefits career trajectory and compensation negotiating position.
Lobbying and Political
  • •Registered lobbyists: Sentara maintains a multi-lobbyist operation in Richmond, including a Vice President of Government Relations & Public Policy, a Vice President of Government Relations, a Director of Health Policy, and a Senior Community and Government Advocate — all handling matters pertaining to Sentara Healthcare and its subsidiaries.
  • •External lobbying firms: The Richmond firm Vectre Corp has deployed up to five lobbyists per year on Sentara's behalf, tracking 20+ bills per General Assembly session and lobbying the Governor's office and executive branch agencies. A separate boutique firm represented both Sentara and Optima Health, with lobbyist Kenneth Hutcheson working the legislature and executive branch.
  • •Political connections: Anna James, a top aide to former Virginia Governor Terry McAuliffe, oversees Sentara's lobbying efforts. Her twin sister, Megan Healy, served as a top official in Governor Ralph Northam's administration — an unusual dual-family political pipeline connecting Sentara to two consecutive Virginia governorships.
  • •Lobbying expenditures: VPAP (Virginia Public Access Project) records show Sentara spending $125,297 in the May 2009–April 2010 reporting period alone. More recent spending is tracked on VPAP but totals were not extracted in available search results. The Checks and Balances Project described Sentara as "a new power player in Virginia government," noting the system's "heavy use of lobbyists, attorneys and others" to maintain its market position.
  • •Sentara is a major member institution of the VHHA, which serves as the state-level hospital trade association and coordinates with the AHA at the federal level.
  • •HosPAC is VHHA's political action committee. It raised over $165,000 in 2021 to support candidates for statewide office and the Virginia General Assembly. Critically, eligible contributions raised through HosPAC are shared with AHAPAC (the AHA's federal PAC) — establishing a direct financial conduit from Virginia hospital money to AHA political activities.
  • •VHHA federal lobbying: VHHA has spent $2.04 million across 78 lobbying disclosures over the past decade. External firms include K&L Gates LLP ($450,000 since 2023) and Holland & Knight ($220,000 for Medicaid state-directed payment lobbying). Priorities include Medicare and Medicaid payment policies, rural hospital sustainability, 340B drug pricing program defense, and hospital workforce issues — all issues where AHA board members like Hancock set trade association policy.
  • •The AHA is the single largest healthcare lobbying organization in the U.S., consistently spending $25–30 million annually on federal lobbying. As a board member, Hancock participates in governing the body that directs this spending.

Red Flags

Unclear and potentially deceptive financial assistance policies

Charging uninsured patients higher rates than insured patients (the opposite of what charity care obligations imply)

Using its "Transparent Pricing Tool" to display prices that were lower than what patients were actually billed

Aggressive conduct against competitors (particularly DePaul Hospital) inconsistent with charitable purpose

If the IRS determined the violations were egregious, Sentara could face loss of tax-exempt status and potential back-tax liability that could consume a significant portion of its $6 billion in reserves.

Poached DePaul's physicians

Fought Bon Secours DePaul's Certificate of Public Need (COPN) applications to update programs

Systematically undermined DePaul's financial viability

Big Four auditor (Ernst & Young, Deloitte) → health system finance → consulting partner advising on payment model transformation → health system CFO → AHA board member

Each step deepens the alignment between personal career incentives and the institutional interest in maintaining the current reimbursement regime. Her HFMA national chairmanship (2015–16) and AHA Regional Policy Board service (2021–23) were stepping stones to the national board — a well-worn path that ensures the AHA board is populated by executives with deep financial stakes in the policies it advocates.

Pattern Summary

Melinda S. Hancock represents the purest expression of the CFO-to-trade-association-board pipeline.